Cargando…
Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient?
Metastatic breast cancer is generally considered incurable. However, some patients show an exceptional response to treatment and enjoy long-term survival in good health. Here, we present a remarkable example of a patient who is still in remission 19 years after high-dose chemotherapy and locoregiona...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727954/ https://www.ncbi.nlm.nih.gov/pubmed/26848422 http://dx.doi.org/10.7759/cureus.433 |
_version_ | 1782412047008399360 |
---|---|
author | Steenbruggen, Tessa G Linn, Sabine C Rodenhuis, Sjoerd Sonke, Gabe S |
author_facet | Steenbruggen, Tessa G Linn, Sabine C Rodenhuis, Sjoerd Sonke, Gabe S |
author_sort | Steenbruggen, Tessa G |
collection | PubMed |
description | Metastatic breast cancer is generally considered incurable. However, some patients show an exceptional response to treatment and enjoy long-term survival in good health. Here, we present a remarkable example of a patient who is still in remission 19 years after high-dose chemotherapy and locoregional treatment for limited oligometastatic breast cancer. We will outline our rationale for this treatment to explain her excellent response and suggest strategies to select larger patient groups that could similarly benefit from existing treatment approaches. |
format | Online Article Text |
id | pubmed-4727954 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-47279542016-02-04 Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient? Steenbruggen, Tessa G Linn, Sabine C Rodenhuis, Sjoerd Sonke, Gabe S Cureus Oncology Metastatic breast cancer is generally considered incurable. However, some patients show an exceptional response to treatment and enjoy long-term survival in good health. Here, we present a remarkable example of a patient who is still in remission 19 years after high-dose chemotherapy and locoregional treatment for limited oligometastatic breast cancer. We will outline our rationale for this treatment to explain her excellent response and suggest strategies to select larger patient groups that could similarly benefit from existing treatment approaches. Cureus 2015-12-24 /pmc/articles/PMC4727954/ /pubmed/26848422 http://dx.doi.org/10.7759/cureus.433 Text en Copyright © 2015, Steenbruggen et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Oncology Steenbruggen, Tessa G Linn, Sabine C Rodenhuis, Sjoerd Sonke, Gabe S Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient? |
title | Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient? |
title_full | Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient? |
title_fullStr | Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient? |
title_full_unstemmed | Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient? |
title_short | Ongoing Remission Nineteen Years after High-dose Chemotherapy for Oligometastatic Breast Cancer; What Can We Learn from this Patient? |
title_sort | ongoing remission nineteen years after high-dose chemotherapy for oligometastatic breast cancer; what can we learn from this patient? |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727954/ https://www.ncbi.nlm.nih.gov/pubmed/26848422 http://dx.doi.org/10.7759/cureus.433 |
work_keys_str_mv | AT steenbruggentessag ongoingremissionnineteenyearsafterhighdosechemotherapyforoligometastaticbreastcancerwhatcanwelearnfromthispatient AT linnsabinec ongoingremissionnineteenyearsafterhighdosechemotherapyforoligometastaticbreastcancerwhatcanwelearnfromthispatient AT rodenhuissjoerd ongoingremissionnineteenyearsafterhighdosechemotherapyforoligometastaticbreastcancerwhatcanwelearnfromthispatient AT sonkegabes ongoingremissionnineteenyearsafterhighdosechemotherapyforoligometastaticbreastcancerwhatcanwelearnfromthispatient |